Germany’s progressive stance on cannabis regulation has seen the country be at the forefront of the cannabis legalisation conversation in Europe for the last two years, fostering a rapidly growing market with significant potential. Already the largest medical cannabis market in Europe by way of sales and patient numbers, paired with the impending launch of a fully-regulated adult-use market, Germany is central to the European cannabis industry’s hopes for a bigger and brighter future.
The combined network of Business of Cannabis and Prohibition Partners is the largest B2B audience in the global cannabis industry, ensuring each summit attracts a diverse, and international audience of business leaders and key decision makers from a variety of industries.
The conference agenda will include a wide range of topics and themes to explore the current state of play and future outlook for the German adult-use and medical cannabis markets.